Vancomycin (Iv) Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection

Available Strengths: Lyophilized vials: 500 mg, 750 mg, 1 g; Premixed IV bags: 500 mg/100 mL, 1 g/200 mL

Reference Brands: Vancocin(US)

Category: Critical Care

Vancomycin IV treats serious Gram-positive infections like MRSA and sepsis. Available in 500 mg to 1 g vials or premixed infusion bags, brands include Vancocin and generics. Pharma B2B platforms offer consistent Vancomycin supply for hospitals, ICUs, and institutional buyers requiring quality-assured critical care antibiotics. Vancomycin (IV) is available in Intravenous (IV) Injection and strengths such as Lyophilized vials: 500 mg, 750 mg, 1 g; Premixed IV bags: 500 mg/100 mL, 1 g/200 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Vancomycin (IV) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Vancomycin (IV) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Vancomycin IV is a glycopeptide antibiotic widely used in hospitals to treat severe Gram-positive infections, including MRSA, sepsis, endocarditis, and bone infections. It is available as a lyophilized powder (500 mg, 750 mg, 1 g) or in ready-to-infuse bags (500 mg/100 mL, 1 g/200 mL). In the US, Vancocin and generic Vancomycin are supplied by ANI, Pfizer, Fresenius, and Mylan. In the EU, Sandoz, Accord, and Hikma lead distribution. Vancomycin is essential in critical care and infectious disease treatment. Pharma B2B platforms streamline Vancomycin bulk procurement for hospitals, clinics, and government tenders worldwide.